RS56523B1 - Tapentadol za sprečavanje i lečenje depresije i anksioznosti - Google Patents
Tapentadol za sprečavanje i lečenje depresije i anksioznostiInfo
- Publication number
- RS56523B1 RS56523B1 RS20171076A RSP20171076A RS56523B1 RS 56523 B1 RS56523 B1 RS 56523B1 RS 20171076 A RS20171076 A RS 20171076A RS P20171076 A RSP20171076 A RS P20171076A RS 56523 B1 RS56523 B1 RS 56523B1
- Authority
- RS
- Serbia
- Prior art keywords
- pain
- tapentadol
- depression
- anxiety
- neuropathic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Rheumatology (AREA)
- Anesthesiology (AREA)
- Dermatology (AREA)
- Psychiatry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11003508 | 2011-04-29 | ||
| EP12720794.2A EP2701693B1 (en) | 2011-04-29 | 2012-04-27 | Tapentadol for preventing and treating depression and anxiety |
| PCT/EP2012/001819 WO2012146383A1 (en) | 2011-04-29 | 2012-04-27 | Tapentadol for preventing and treating depression and anxiety |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RS56523B1 true RS56523B1 (sr) | 2018-02-28 |
Family
ID=44260882
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RS20171076A RS56523B1 (sr) | 2011-04-29 | 2012-04-27 | Tapentadol za sprečavanje i lečenje depresije i anksioznosti |
| RS20200431A RS60152B1 (sr) | 2011-04-29 | 2012-04-27 | Tapentadol za sprečavanje i lečenje depresije i anksioznosti |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RS20200431A RS60152B1 (sr) | 2011-04-29 | 2012-04-27 | Tapentadol za sprečavanje i lečenje depresije i anksioznosti |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US20120277319A1 (enExample) |
| EP (3) | EP2701693B1 (enExample) |
| JP (3) | JP6014655B2 (enExample) |
| CY (2) | CY1119586T1 (enExample) |
| DK (2) | DK3272343T3 (enExample) |
| ES (2) | ES2788548T3 (enExample) |
| HR (2) | HRP20171570T1 (enExample) |
| HU (2) | HUE049308T2 (enExample) |
| LT (2) | LT2701693T (enExample) |
| NO (1) | NO2701693T3 (enExample) |
| PL (2) | PL3272343T3 (enExample) |
| PT (2) | PT2701693T (enExample) |
| RS (2) | RS56523B1 (enExample) |
| SI (2) | SI2701693T1 (enExample) |
| WO (1) | WO2012146383A1 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102005005446A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Bruchfeste Darreichungsformen mit retardierter Freisetzung |
| DE10361596A1 (de) | 2003-12-24 | 2005-09-29 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
| DE102004032049A1 (de) | 2004-07-01 | 2006-01-19 | Grünenthal GmbH | Gegen Missbrauch gesicherte, orale Darreichungsform |
| DE102005005449A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
| ES2428938T3 (es) | 2009-07-22 | 2013-11-12 | Grünenthal GmbH | Forma de dosificación resistente a la manipulación y estabilizada frente a la oxidación |
| CA2839123A1 (en) | 2011-07-29 | 2013-02-07 | Grunenthal Gmbh | Tamper-resistant tablet providing immediate drug release |
| PL2736497T3 (pl) | 2011-07-29 | 2018-01-31 | Gruenenthal Gmbh | Tabletka odporna na ingerencję, zapewniająca natychmiastowe uwalnianie leku |
| US10314594B2 (en) | 2012-12-14 | 2019-06-11 | Corquest Medical, Inc. | Assembly and method for left atrial appendage occlusion |
| US10307167B2 (en) | 2012-12-14 | 2019-06-04 | Corquest Medical, Inc. | Assembly and method for left atrial appendage occlusion |
| US10813630B2 (en) | 2011-08-09 | 2020-10-27 | Corquest Medical, Inc. | Closure system for atrial wall |
| US20140142689A1 (en) | 2012-11-21 | 2014-05-22 | Didier De Canniere | Device and method of treating heart valve malfunction |
| US10624862B2 (en) | 2013-07-12 | 2020-04-21 | Grünenthal GmbH | Tamper-resistant dosage form containing ethylene-vinyl acetate polymer |
| EP2845625A1 (en) * | 2013-09-04 | 2015-03-11 | Grünenthal GmbH | Tapentadol for use in the treatment of fibromyalgia and chronic fatigue syndrome |
| WO2015078891A1 (en) | 2013-11-26 | 2015-06-04 | Farmaceutici Formenti S.P.A. | Preparation of a powdery pharmaceutical composition by means of cryo-milling |
| US9566443B2 (en) | 2013-11-26 | 2017-02-14 | Corquest Medical, Inc. | System for treating heart valve malfunction including mitral regurgitation |
| US10842626B2 (en) | 2014-12-09 | 2020-11-24 | Didier De Canniere | Intracardiac device to correct mitral regurgitation |
| PT3302454T (pt) * | 2015-05-26 | 2021-04-01 | Technophage Investig E Desenvolvimento Em Biotecnologia Sa | Composições para utilização no tratamento da doença de parkinson e distúrbios associados |
| AU2016319203A1 (en) | 2015-09-10 | 2018-02-22 | Grünenthal GmbH | Protecting oral overdose with abuse deterrent immediate release formulations |
| US10292948B2 (en) * | 2017-01-11 | 2019-05-21 | Torrent Pharmaceuticals Limited | Tapentadol nasal composition |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4783337A (en) | 1983-05-11 | 1988-11-08 | Alza Corporation | Osmotic system comprising plurality of members for dispensing drug |
| US4765989A (en) | 1983-05-11 | 1988-08-23 | Alza Corporation | Osmotic device for administering certain drugs |
| US4612008A (en) | 1983-05-11 | 1986-09-16 | Alza Corporation | Osmotic device with dual thermodynamic activity |
| DE4426245A1 (de) | 1994-07-23 | 1996-02-22 | Gruenenthal Gmbh | 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung |
| PE20030527A1 (es) | 2001-10-24 | 2003-07-26 | Gruenenthal Chemie | Formulacion farmaceutica con liberacion retardada que contiene 3-(3-dimetilamino-1-etil-2-metil-propil) fenol o una sal farmaceuticamente aceptable del mismo y tabletas para administracion oral que la contienen |
| CA2620364A1 (en) | 2005-08-26 | 2007-03-01 | David C. Yeomans | Methods for treatment of headaches by administration of oxytocin |
| US20090306050A1 (en) | 2006-02-03 | 2009-12-10 | Timothy Dinan | Treatment and prevention of depression with pain, depression secondary to pain, and of neuropathic pain |
| PL2012763T3 (pl) | 2006-04-28 | 2011-08-31 | Gruenenthal Gmbh | Kombinacja farmaceutyczna zawierająca 3-(3-dimetyloamino-1-etylo-2-metylo-propylo)-fenol i NSAID |
| DE102007012165A1 (de) | 2007-03-12 | 2008-09-18 | Grünenthal GmbH | Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie des Neuropathieschmerzes |
| EP1985292A1 (en) | 2007-04-23 | 2008-10-29 | Grünenthal GmbH | Titration of tapentadol |
| CN102065852B (zh) | 2007-11-23 | 2015-06-17 | 格吕伦塔尔有限公司 | 他喷他多组合物 |
| US20100297181A1 (en) | 2007-12-26 | 2010-11-25 | Eisai R&D Management Co., Ltd. | AMPA Receptor Antagonists for Epilepsy, Mental Disorders or Deficits in Sensory Organ |
| US7872046B2 (en) | 2008-01-25 | 2011-01-18 | Xenoport, Inc. | Crystalline form of a (3S)-aminomethyl-5-methyl-hexanoic acid prodrug and methods of use |
| WO2009094577A2 (en) | 2008-01-25 | 2009-07-30 | Xenoport, Inc. | Mesophasic forms of (3s)-aminomethyl-5-methyl-hexanoic acid prodrugs and methods of use |
| WO2010100477A2 (en) | 2009-03-03 | 2010-09-10 | Shire Llc | Amino acid and peptide carbamate prodrugs of tapentadol and uses thereof |
| MX2011011442A (es) | 2009-04-30 | 2011-11-18 | Gruenenthal Gmbh | Uso de compuestos de 1-fenil-3-dimetilaminopropano para tratar dolor reumatoide. |
| FR2970261B1 (fr) | 2011-01-10 | 2013-05-03 | IFP Energies Nouvelles | Procede d'hydrotraitement de charges lourdes d'hydrocarbures avec des reacteurs permutables incluant au moins une etape de permutation progressive |
| EP2694049B1 (en) | 2011-04-05 | 2018-10-31 | Grünenthal GmbH | Tapentadol for preventing chronification of pain |
-
2012
- 2012-04-27 NO NO12720794A patent/NO2701693T3/no unknown
- 2012-04-27 EP EP12720794.2A patent/EP2701693B1/en active Active
- 2012-04-27 WO PCT/EP2012/001819 patent/WO2012146383A1/en not_active Ceased
- 2012-04-27 HU HUE17185830A patent/HUE049308T2/hu unknown
- 2012-04-27 PT PT127207942T patent/PT2701693T/pt unknown
- 2012-04-27 EP EP19218383.8A patent/EP3656380A1/en not_active Withdrawn
- 2012-04-27 US US13/458,510 patent/US20120277319A1/en not_active Abandoned
- 2012-04-27 HU HUE12720794A patent/HUE034003T2/en unknown
- 2012-04-27 SI SI201231099T patent/SI2701693T1/sl unknown
- 2012-04-27 ES ES17185830T patent/ES2788548T3/es active Active
- 2012-04-27 PL PL17185830T patent/PL3272343T3/pl unknown
- 2012-04-27 RS RS20171076A patent/RS56523B1/sr unknown
- 2012-04-27 RS RS20200431A patent/RS60152B1/sr unknown
- 2012-04-27 HR HRP20171570TT patent/HRP20171570T1/hr unknown
- 2012-04-27 DK DK17185830.1T patent/DK3272343T3/da active
- 2012-04-27 JP JP2014506793A patent/JP6014655B2/ja not_active Expired - Fee Related
- 2012-04-27 LT LTEP12720794.2T patent/LT2701693T/lt unknown
- 2012-04-27 LT LTEP17185830.1T patent/LT3272343T/lt unknown
- 2012-04-27 PL PL12720794T patent/PL2701693T3/pl unknown
- 2012-04-27 ES ES12720794.2T patent/ES2646363T3/es active Active
- 2012-04-27 DK DK12720794.2T patent/DK2701693T3/da active
- 2012-04-27 EP EP17185830.1A patent/EP3272343B1/en active Active
- 2012-04-27 PT PT171858301T patent/PT3272343T/pt unknown
- 2012-04-27 SI SI201231768T patent/SI3272343T1/sl unknown
-
2014
- 2014-09-30 US US14/502,552 patent/US20150018426A1/en not_active Abandoned
-
2016
- 2016-09-20 JP JP2016183088A patent/JP2017031182A/ja active Pending
-
2017
- 2017-03-27 US US15/470,385 patent/US9980927B2/en active Active
- 2017-08-29 JP JP2017163838A patent/JP6445637B2/ja not_active Expired - Fee Related
- 2017-11-10 CY CY20171101178T patent/CY1119586T1/el unknown
-
2020
- 2020-04-15 HR HRP20200600TT patent/HRP20200600T1/hr unknown
- 2020-04-16 CY CY20201100360T patent/CY1123051T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RS56523B1 (sr) | Tapentadol za sprečavanje i lečenje depresije i anksioznosti | |
| JP6441267B2 (ja) | 過活動膀胱を治療するためのβ−３アドレナリン受容体アゴニストおよびムスカリン受容体アンタゴニストの組み合わせ | |
| ES2433080T3 (es) | Inhibidores selectivos de la recaptación de norepinefrina-serotonina para el tratamiento del síndrome de fibromialgia, síndrome de fatiga crónica y dolor | |
| US20080021074A1 (en) | Pharmaceutical Compositions and Related Methods of Treatment | |
| US10517841B1 (en) | Compositions and methods for treating respiratory depression with fenfluramine | |
| KR20200016889A (ko) | 과다 졸림증을 치료하기 위한 방법 및 조성물 | |
| NO317855B1 (no) | Anvendelse av selegilin eller et farmasoytisk akseptabelt salt derav. | |
| CN102985085A (zh) | 治疗双相型障碍的方法 | |
| JP2021526507A (ja) | 発作により誘発される突然死を処置するための組成物および方法 | |
| WO2013063289A1 (en) | Pharmaceutical compositions for treating pain | |
| JP2016074728A (ja) | 脱髄性および他の神経系疾患を患っている患者における神経認知的および／または神経精神医学的障害を改善するための４−アミノピリジンの使用 | |
| US20240197756A1 (en) | Methods of treatment with neuroactive steroids | |
| KR102232198B1 (ko) | 의약으로서 사용되기 위한 (r)-펄린돌 및 약학적으로 허용 가능한 그의 염 | |
| JP2005314347A (ja) | 疼痛抑制剤 | |
| KR101565505B1 (ko) | 에페리손을 함유하는 새로운 약물 전달 시스템 | |
| RU2797615C2 (ru) | Способы применения феноксипропиламинового соединения для лечения боли | |
| KR20240054306A (ko) | 통증 및 연관 증상을 예방하고 치료하는 방법 | |
| EP4673132A1 (en) | Methods of treating essential tremor | |
| EP3087984B1 (en) | Prophylactic and therapeutic agent for attention-deficit/hyperactivity disorder | |
| CN114080221A (zh) | 用于减轻疼痛的布洛芬与曲马多的组合 | |
| WO2018069770A1 (en) | Methods of treatment using eluxadoline | |
| CA3066904A1 (en) | Bromhexine for the treatment of pain |